Pillstats
Rx only · Solution · Nasal

Esketamine Hydrochloride

Brands: Spravato · Esketamine Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AX27
RxCUI (US)2119365
US makers1 labelers
Packages2
DEA / ScheduleCIII

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$123.35$246.70$370.04$493.39Dec 2025Jun 2026Jul 2026
$429.037
Latest avg · Jul 22, 2026
+8%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

32K64K96K128K2025 Q12025 Q22025 Q32025 Q42026 Q1
97K
Rx · 2026 Q1
370K
Units dispensed
+27%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Janssen Pharmaceuticals, Inc.unknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.